Patent details
EP1229918 Title: PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND GLIBENCLAMIDE
Basic Information
- Publication number:
- EP1229918
- PCT Application Number:
- PCT/US/2000/028311
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009721226
- PCT Publication Number:
- WO/2001/032157
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND GLIBENCLAMIDE
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE COMPRENANT UNE COMBINAISON DE METFORMINE ET DE GLIBENCLAMIDE
- German Title of Invention:
- ARZNEIMITTEL, UMFASSEND EINE KOMBINATION AUS METFORMIN UND GLIBENCLAMIDE
- SPC Number:
Dates
- Filing date:
- 13/10/2000
- Grant date:
- 26/03/2008
- EP Publication Date:
- 26/03/2008
- PCT Publication Date:
- 10/05/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/08/2002
- EP B1 Publication Date:
- 26/03/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/10/2008
- Expiration date:
- 13/10/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/10/2000
- Name:
- Bristol-Myers Squibb Company
- Address:
- P.O. Box 4000, Princeton, NJ 08543-4000, United States (US)
Inventor
- Name:
- PIPER Beth, Anne
- Address:
- United States (US)
Priority
1
- Priority Number:
- 432465
- Priority Date:
- 03/11/1999
- Priority Country:
- United States (US)
2
- Priority Number:
- 460920
- Priority Date:
- 14/12/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/64;
| Filing date | Document type | Number of pages |
|---|